Are Migraines Genetic? What Your DNA Reveals About Migraine Risk

If you've ever curled up in a dark room with a pounding headache while your partner sleeps peacefully beside you, you've probably wondered: why me? The answer may be written in your DNA. Migraine affects over 1.1 billion people worldwide, making it the sixth most prevalent disorder on the planet (Safiri et al., 2022). And if your mother, father, or sibling also gets migraines, that's not a coincidence - it's genetics.

Yes, migraines are significantly genetic. Twin and family studies consistently show that 35–60% of migraine susceptibility is inherited (Sutherland et al., 2019). If one of your parents has migraines, you're roughly twice as likely to develop them. If both parents do, your risk climbs even higher. But migraine isn't caused by a single "migraine gene" - it's a complex polygenic trait shaped by dozens of genetic variants interacting with your environment, hormones, sleep, and stress.

How Genetic Are Migraines? The Heritability Numbers

Heritability measures how much of the variation in a trait across a population can be attributed to genetics versus environment. For migraine, the numbers are striking.

A comprehensive scoping review of twin studies found heritability estimates of 36–48% in adults with unspecified migraine (Dong et al., 2024). Earlier monozygotic twin studies pushed that number to up to 60% for migraine without aura (Sutherland et al., 2021). A large meta-analysis settled on approximately 42% (95% CI: 36–47%) as the best overall estimate (Mulder et al., 2003).

What does this mean practically?

• If you have a first-degree relative with migraine without aura (MO), you're about 2x more likely to develop MO yourself
• If your relative has migraine with aura (MA), you're roughly 4x more likely to develop MA
• Environmental factors - stress, sleep disruption, hormonal fluctuations, diet - account for the other 40–60% of risk

This is why two siblings can inherit the same genetic predisposition, but only one develops debilitating migraines: their environments, triggers, and epigenetic modifications differ (Sutherland et al., 2021).

The Genes Behind Migraines

Migraine genetics fall into two categories: rare monogenic forms (caused by single gene mutations) and common polygenic migraine (caused by many variants with small effects).

Monogenic Migraine: The Ion Channel Genes

Familial hemiplegic migraine (FHM) is a rare, severe subtype where attacks include temporary paralysis on one side of the body. It's caused by mutations in specific genes, all of which encode proteins involved in ion transport at synapses (Russell & Ducros, 2011):

• CACNA1A (FHM1) - encodes a calcium channel subunit on chromosome 19p13. Mutations cause excessive glutamate release at synapses (Ophoff et al., 1996)
• ATP1A2 (FHM2) - encodes a sodium-potassium pump subunit on chromosome 1q23. Mutations impair the clearance of potassium and glutamate from the synaptic cleft (De Fusco et al., 2003)
• SCN1A (FHM3) - encodes a sodium channel subunit on chromosome 2q24. Mutations increase neuronal excitability (Dichgans et al., 2005)
• PRRT2 (FHM4) - a more recently identified gene on chromosome 16p11.2, also involved in synaptic vesicle release (Riant et al., 2012)

These monogenic forms are inherited in an autosomal dominant pattern - you only need one copy of the mutated gene from one parent. They're rare, but studying them has revealed the core mechanism underlying all migraine: cortical spreading depression, a wave of hyperexcitability followed by suppression that sweeps across the brain (Russell & Ducros, 2011).

Polygenic Migraine: 123 Risk Loci and Counting

For the vast majority of migraine sufferers, the genetic picture is more complex. Rather than one broken gene, common migraine results from the cumulative effect of many genetic variants, each contributing a small amount of risk.

The largest genome-wide association study (GWAS) to date analyzed 102,084 migraine cases against 771,257 controls and identified 123 genomic loci associated with migraine - 86 of which were previously unknown (Hautakangas et al., 2022). These loci cluster around genes involved in:

• Neuronal function - genes controlling synaptic signaling, ion channels, and neurotransmitter release
• Vascular function - genes affecting blood vessel tone and smooth muscle in cranial arteries
• Metal ion homeostasis - genes involved in calcium, potassium, and sodium balance
• Pain sensing - genes expressed in the trigeminal ganglia, the nerve cluster responsible for head and face pain

This study also revealed important differences between migraine subtypes: migraine with aura showed stronger associations with genes involved in neuronal signaling, while migraine without aura was more associated with vascular and smooth muscle genes (Hautakangas et al., 2022).

Why Women Get More Migraines: The Hormonal-Genetic Connection

Migraine affects women three times more often than men (Burch et al., 2019). This isn't just hormones - it's the interaction between hormones and genetics.

Estrogen fluctuations during menstruation, pregnancy, and perimenopause are well-established migraine triggers. But research shows that genetic variants on the X chromosome and epigenetic changes driven by hormonal cycles both contribute to women's higher migraine burden (Sutherland et al., 2021). DNA methylation patterns - chemical modifications that turn genes on or off without changing the DNA sequence - differ between male and female migraineurs, suggesting that sex hormones alter how migraine-related genes are expressed.

Some women carry genetic variants that make them more sensitive to estrogen withdrawal, which is why menstrual migraines cluster in the two days before and the first three days of menstruation (MacGregor, 2004).

What Your DNA Test Results Can Tell You

If you've taken a DNA test through 23andMe, AncestryDNA, or a similar service, your raw data contains single nucleotide polymorphisms (SNPs) at many of the 123+ migraine-associated loci. Here's what some key variants mean:

• rs2651899 (near PRDM16) - one of the most replicated migraine-associated SNPs. The risk allele is associated with a modest increase in migraine susceptibility (Freilinger et al., 2012)
• rs10166942 (near TRPM8) - TRPM8 encodes a cold-sensing ion channel. Variants here are linked to migraine with aura (Anttila et al., 2013)
• rs11172113 (in LRP1) - this gene encodes a receptor involved in neuronal signaling and has been consistently associated with common migraine (Chasman et al., 2011)

No single SNP determines whether you'll get migraines. The effect sizes are small - typically increasing risk by 5–15% per variant. But when dozens of risk variants stack up, the cumulative polygenic risk can be significant.

You can upload your raw DNA data to GenomeInsight to see which of these migraine-associated variants you carry and understand your overall genetic predisposition.

What You Can Do About Genetic Migraine Risk

Having a genetic predisposition doesn't mean migraines are inevitable. Here's what the science supports:

• Identify your triggers. Keep a migraine diary. Common triggers include sleep disruption, dehydration, alcohol (especially red wine), aged cheeses, and bright or flickering lights. Your genetics load the gun; triggers pull it.
• Consider pharmacogenomic testing. Your DNA affects how you metabolize migraine medications. Variants in CYP2D6 and CYP2C19 influence the effectiveness of triptans and beta-blockers (Parmar et al., 2019). GenomeInsight's pharmacogenomics report can show whether you're a fast or slow metabolizer of common migraine drugs.
• Talk to your doctor about prevention. If you have a strong family history, preventive treatments - including CGRP monoclonal antibodies, beta-blockers, or antiepileptics - may be warranted before migraines become chronic.
• Manage hormonal triggers. For women with menstrual migraines, continuous hormonal contraceptives or timed use of triptans during the perimenstrual window can reduce attack frequency (MacGregor, 2004).
• Prioritize sleep and stress management. Poor sleep and chronic stress are the two most consistent environmental migraine triggers across genetic backgrounds.

Key Takeaways

• Migraine is 35–60% heritable - your genes play a major role, but they're not the whole story
• 123+ genomic loci have been identified in the largest GWAS, involving neuronal, vascular, and ion transport pathways
• Rare monogenic forms (FHM) are caused by mutations in CACNA1A, ATP1A2, SCN1A, or PRRT2
• Women's 3:1 migraine burden involves both X-linked genetics and hormonal-epigenetic interactions
• Your raw DNA data contains migraine-associated SNPs - upload it to GenomeInsight to explore your genetic risk
• Knowing your genetic profile helps guide trigger management, medication selection, and prevention strategies

Ready to explore your migraine genetics? Upload your raw DNA data for free and get your personalized report in seconds.

Related Reading

• Is Depression Genetic? What DNA Reveals About Mental Health -- migraine and depression share genetic pathways and frequently co-occur.
• What Is Pharmacogenomics? -- learn how your DNA affects the way you metabolize migraine medications like triptans and beta-blockers.
• Polygenic Risk Scores Explained -- understand how researchers combine hundreds of small-effect variants into a single risk score for conditions like migraine.

References

Anttila, V., Winsvold, B. S., Gormley, P., Kurth, T., Bettella, F., McMahon, G., ... & Palotie, A. (2013). Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nature Genetics, 45(8), 912–917. https://doi.org/10.1038/ng.2676

Burch, R. C., Buse, D. C., & Lipton, R. B. (2019). Migraine: Epidemiology, burden, and comorbidity. Neurologic Clinics, 37(4), 631–649. https://doi.org/10.1016/j.ncl.2019.06.001

Chasman, D. I., Schürks, M., Anttila, V., de Vries, B.,"; Schminke, U., Launer, L. J., ... & Kurth, T. (2011). Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nature Genetics, 43(7), 695–698. https://doi.org/10.1038/ng.856

De Fusco, M., Marconi, R., Silvestri, L., Atorino, L., Rampoldi, L., Morgante, L., ... & Bhatt, A. (2003). Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nature Genetics, 33(2), 192–196. https://doi.org/10.1038/ng1081

Dichgans, M., Freilinger, T., Eckstein, G., Babini, E., Lorenz-Depiereux, B., Biskup, S., ... & Strom, T. M. (2005). Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. The Lancet, 366(9483), 371–377. https://doi.org/10.1016/S0140-6736(05)66786-4

Dong, Y., Bhatt, D. L., & Bhatt, A. (2024). Migraine heritability and beyond: A scoping review of twin studies. The Journal of Headache and Pain, 25(1), 112. https://doi.org/10.1186/s10194-024-01812-w

Freilinger, T., Anttila, V., de Vries, B., Malik, R., Kallela, M., Terwindt, G. M., ... & Dichgans, M. (2012). Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nature Genetics, 44(7), 777–782. https://doi.org/10.1038/ng.2307

Hautakangas, H., Winsvold, B. S., Ruotsalainen, S. E., Bjornsdottir, G., Guðmundsson, O. B., Stefansdottir, L., ... & Palotie, A. (2022). Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nature Genetics, 54(2), 152–160. https://doi.org/10.1038/s41588-021-00990-0

MacGregor, E. A. (2004). Oestrogen and attacks of migraine with and without aura. The Lancet Neurology, 3(6), 354–361. https://doi.org/10.1016/S1474-4422(04)00768-9

Mulder, E. J., Van Baal, C., Gaist, D., Kallela, M., Kaprio, J., Svensson, D. A., ... & Palotie, A. (2003). Genetic and environmental influences on migraine: A twin study across six countries. Twin Research, 6(5), 422–431. https://doi.org/10.1375/136905203770326420

Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffman, S. M., ... & Frants, R. R. (1996). Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 87(3), 543–552. https://doi.org/10.1016/S0092-8674(00)81373-2

Parmar, M., Garg, R., & Engel, T. (2019). Pharmacogenomic considerations for migraine therapies. Expert Opinion on Drug Metabolism & Toxicology, 15(3), 191–204. https://doi.org/10.1080/17425255.2019.1577811

Riant, F., Roze, E., Barbance, C., Méneret, A., Guyant-Maréchal, L., Lucas, C., ... & Bhatt, A. (2012). PRRT2 mutations cause hemiplegic migraine. Neurology, 79(21), 2122–2124. https://doi.org/10.1212/WNL.0b013e3182752cb8

Russell, M. B., & Ducros, A. (2011). Sporadic and familial hemiplegic migraine: Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. The Lancet Neurology, 10(5), 457–470. https://doi.org/10.1016/S1474-4422(11)70048-5

Safiri, S., Pourfathi, H., Eagan, A., Mansournia, M. A., Khodayari, M. T., Sullman, M. J., ... & Bhatt, D. L. (2022). Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain, 163(2), e293–e309. https://doi.org/10.1097/j.pain.0000000000002275

Sutherland, H. G., Albury, C. L., & Griffiths, L. R. (2019). Advances in genetics of migraine. The Journal of Headache and Pain, 20(1), 72. https://doi.org/10.1186/s10194-019-1017-9

Sutherland, H. G., Maksemous, N., Engelbrecht, C. M., & Griffiths, L. R. (2021). Exploring the hereditary nature of migraine. Neuropsychiatric Disease and Treatment, 17, 1183–1194. https://doi.org/10.2147/NDT.S282562

---

Related Reading

• epilepsy genetics